Product Description: Semaglutide, FITC labeled is a FITC labeled Semaglutide. Semaglutide, a long-acting GLP-1 alogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide has the potential for type 2 diabetes treatment[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C209H304N46O63S
References: [1]Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844.
Molecular Weight: 4500.99
Research Area: Metabolic Disease
Target: GCGR